MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144,615,802 | +18.1% | 3,319,922 | -2.0% | 0.03% | +26.1% |
| Q2 2023 | $122,421,628 | +22.1% | 3,388,365 | +25.7% | 0.02% | +15.0% |
| Q1 2023 | $100,240,700 | -26.7% | 2,696,092 | -10.6% | 0.02% | -25.9% |
| Q4 2022 | $136,670,140 | -43.6% | 3,016,335 | -13.1% | 0.03% | -48.1% |
| Q3 2022 | $242,297,000 | +24.2% | 3,469,311 | +19.4% | 0.05% | +33.3% |
| Q2 2022 | $195,082,000 | -4.4% | 2,906,030 | +17.1% | 0.04% | +11.4% |
| Q1 2022 | $204,113,000 | -55.8% | 2,482,521 | -21.1% | 0.04% | -52.7% |
| Q4 2021 | $461,606,000 | -24.2% | 3,146,815 | -8.5% | 0.07% | -28.8% |
| Q3 2021 | $608,611,000 | +21.4% | 3,440,222 | +10.9% | 0.10% | +25.3% |
| Q2 2021 | $501,306,000 | +33.8% | 3,103,485 | +41.9% | 0.08% | +25.8% |
| Q1 2021 | $374,534,000 | -24.4% | 2,186,418 | -3.0% | 0.07% | -27.5% |
| Q4 2020 | $495,262,000 | +82.2% | 2,254,882 | +37.7% | 0.09% | +62.5% |
| Q3 2020 | $271,893,000 | +32.0% | 1,637,420 | -9.3% | 0.06% | +21.7% |
| Q2 2020 | $206,042,000 | +54.4% | 1,804,701 | +4.0% | 0.05% | +31.4% |
| Q1 2020 | $133,443,000 | +74.0% | 1,735,957 | +191.7% | 0.04% | +118.8% |
| Q4 2019 | $76,694,000 | +552.4% | 595,180 | +294.5% | 0.02% | +433.3% |
| Q3 2019 | $11,755,000 | +157.4% | 150,885 | +240.2% | 0.00% | +200.0% |
| Q2 2019 | $4,567,000 | +543.2% | 44,347 | +357.7% | 0.00% | – |
| Q1 2019 | $710,000 | +51.4% | 9,689 | +1.8% | 0.00% | – |
| Q2 2018 | $469,000 | – | 9,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |